Lorlatinib for the Treatment of ALK Fusion-Positive Infant-Type Hemispheric Glioma: A Case Report

JCO Precis Oncol. 2022 Oct:6:e2200255. doi: 10.1200/PO.22.00255.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Glioma* / drug therapy
  • Humans
  • Lactams, Macrocyclic / therapeutic use
  • Pyrazoles* / therapeutic use
  • Receptor Protein-Tyrosine Kinases / genetics

Substances

  • lorlatinib
  • Lactams, Macrocyclic
  • Pyrazoles
  • Receptor Protein-Tyrosine Kinases